| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Total Revenue | $1.89B (+11% YoY in Q3) | $2.0B (+13% YoY) | Accelerated 200bps vs Q3 |
| Organic Revenue | 4% YoY growth in Q3 | 5% YoY growth | 100bps acceleration |
| EPS | $1.89 (+14% YoY in Q3) | $2.01 (+7% YoY) | 700bps deceleration in growth |
| Operating Margin | 26.2% (up 90bps in Q3) | 26.2% | Flat sequentially |
| Core Operating Margin | 27.0% (up 90bps in Q3) | 27.6% | 60bps expansion |
| EMG Operating Margin | 25.4% (up 250bps YoY in Q3) | 22.7% | 270bps sequential decline |
| EIG Organic Growth | Flat YoY in Q3 | 2% YoY growth | First positive organic since recovery |
| EMG Organic Growth | 12% YoY in Q3 | 14% YoY growth | 200bps acceleration |
| Backlog | $3.54B (record in Q3) | $3.58B | New record, up $40M |
| Free Cash Flow | $420M in Q3 | $527M | 25% sequential increase |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.